Healthcare Sector

LLY

Market Tracker

$1,068.00
+47.16
(+4.62%)
5:20 pm
Next Earnings: (est.) 08/08/23 12:00 am
  • LLY (Selected)

    Eli Lilly and Company
  • LLYVA

  • LLYVK

  • LLYX

LLY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

LLY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LLY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LLY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

LLY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LLY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
03/20/2026 PUT $920.00 1,144 +696 +155.36%
02/13/2026 CALL $1,200.00 933 +445 +91.19%
02/06/2026 CALL $1,100.00 1,542 +415 +36.82%
02/20/2026 CALL $1,080.00 838 +343 +69.29%
02/06/2026 PUT $950.00 858 +279 +48.19%
06/18/2026 PUT $900.00 652 +263 +67.61%
03/20/2026 CALL $1,100.00 1,894 -151 -7.38%
02/20/2026 CALL $1,070.00 579 -170 -22.70%
02/06/2026 CALL $1,200.00 1,121 -190 -14.49%
02/20/2026 CALL $1,130.00 692 -321 -31.69%
06/17/2027 CALL $1,300.00 429 -669 -60.93%
06/17/2027 CALL $900.00 413 -670 -61.87%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LLY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.74% 26M 11.45B
Vanguard 500 Index Fund 1.92% 18.23M 8.03B
Vanguard/Primecap Fund 1.56% 14.85M 6.54B
Fidelity 500 Index Fund 0.91% 8.65M 3.81B
SPDR S&P 500 ETF Trust 0.90% 8.54M 3.76B
Vanguard Specialized-Health Care Fund 0.80% 7.64M 3.37B
iShares Core S&P 500 ETF 0.74% 7.04M 3.1B
Washington Mutual Investors Fund 0.73% 6.95M 3.06B
Growth Fund Of America Inc 0.71% 6.7M 2.95B
Select Sector SPDR Fund-Health Care 0.67% 6.41M 2.82B

LLY News

  • Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

    02/07 10:30 pm

    The Motley Fool

    Read more
  • 3 Things Investors Need to Know About the Healthcare Sector in 2026

    02/07 10:13 am

    The Motley Fool

    Read more
  • Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore

    02/06 03:15 pm

    The Motley Fool

    Read more
  • CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

    02/06 02:52 pm

    Benzinga

    Read more
  • Why Shares of Novo Nordisk Stock Collapsed This Week

    02/06 12:31 pm

    The Motley Fool

    Read more
  • Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

    02/06 06:00 am

    GlobeNewswire Inc.

    Read more
  • Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.

    02/05 09:15 pm

    The Motley Fool

    Read more
  • Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst

    02/05 02:44 pm

    Benzinga

    Read more
  • Eli Lilly: Why Investors Are Rewarding It as Novo Slips

    02/05 11:38 am

    Investing.com

    Read more
  • Obesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally

    02/05 05:00 am

    GlobeNewswire Inc.

    Read more
  • Why Eli Lilly Stock Soared Today

    02/04 11:18 pm

    The Motley Fool

    Read more
  • Novo Nordisk Faces a Reality Check as Pricing Pressure Hits 2026 Forecasts

    02/04 03:22 pm

    Investing.com

    Read more
  • In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk

    02/04 03:02 pm

    Benzinga

    Read more
  • Q4 Earnings Summary: Eli Lilly and AbbVie Beat, Uber Mixed

    02/04 12:01 pm

    Investing.com

    Read more
  • Stock Market Today: Dow Futures Gain, Nasdaq Drops As Trump Signs Bill To End Partial Shutdown— AMD, SMCI, LLY In Focus (UPDATED)

    02/04 09:53 am

    Benzinga

    Read more
  • Does Stanley Druckenmiller Know Something Wall Street Doesn't? He Dumped All of His Shares in a Company Dominating a Market That May Soon Be Worth $100 Billion and Opened Positions in 3 AI Giants.

    02/04 07:15 am

    The Motley Fool

    Read more
  • FDA Moves To Bring Pharma Manufacturing Back To US With New Pilot

    02/02 02:11 pm

    Benzinga

    Read more
  • 3 Headwinds Facing Pfizer in 2026

    02/02 07:32 am

    The Motley Fool

    Read more
  • Demand for Novo Nordisk's Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally?

    01/30 07:24 pm

    The Motley Fool

    Read more
  • Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases

    01/30 01:57 pm

    Benzinga

    Read more
  • Should You Buy Eli Lilly Before Feb. 4?

    01/30 08:15 am

    The Motley Fool

    Read more
  • Eli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 Billion

    01/29 02:58 pm

    Benzinga

    Read more
  • Prediction: Artificial Intelligence (AI) Will Reshape This Industry by 2030. This Stock Could Lead.

    01/29 09:05 am

    The Motley Fool

    Read more
  • Can This Beaten-Down AI Stock Bounce Back in 2026?

    01/28 10:01 pm

    The Motley Fool

    Read more
  • Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.

    01/28 09:30 pm

    The Motley Fool

    Read more
  • NVIDIA Sets Conference Call for Fourth-Quarter Financial Results

    01/28 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Chronic and Acute Pain Clinical Trial Pipeline Analysis: 150+ Key Companies Shaping the Future of Chronic and Acute Pain Therapeutics | DelveInsight

    01/28 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss

    01/28 08:00 am

    GlobeNewswire Inc.

    Read more
  • Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

    01/28 06:51 am

    Benzinga

    Read more
  • 1 Biotech Stock Set to Rebound in 2026

    01/28 02:30 am

    The Motley Fool

    Read more
  • Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

    01/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Where Will Eli Lilly Be in 10 Years?

    01/27 10:07 am

    The Motley Fool

    Read more
  • Roche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight

    01/27 07:21 am

    Benzinga

    Read more
  • 3 Growth Stocks to Invest $1,000 in Right Now

    01/24 09:15 pm

    The Motley Fool

    Read more
  • Should You Dump Eli Lilly's Shares After This Setback?

    01/24 04:05 pm

    The Motley Fool

    Read more
  • Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It

    01/23 10:18 am

    Benzinga

    Read more
  • Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026

    01/23 06:10 am

    The Motley Fool

    Read more
  • Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider

    01/22 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights

    01/21 03:42 pm

    GlobeNewswire Inc.

    Read more
  • What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?

    01/20 04:05 pm

    The Motley Fool

    Read more
  • 3 Biotech Stocks to Keep an Eye on in 2026

    01/20 09:41 am

    Investing.com

    Read more
  • Down 55%, Should You Buy the Dip on Pfizer?

    01/19 04:24 pm

    The Motley Fool

    Read more
  • Prediction: 2026 Will Be the Year of Eli Lilly

    01/19 05:10 am

    The Motley Fool

    Read more
  • Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

    01/16 01:38 pm

    GlobeNewswire Inc.

    Read more
  • FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)

    01/16 09:32 am

    Benzinga

    Read more
  • InSilico Lands Drug Discovery Deal After Hong Kong IPO

    01/15 07:44 am

    Benzinga

    Read more
  • Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs

    01/15 04:26 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief

    01/14 03:15 pm

    The Motley Fool

    Read more
  • Why Eli Lilly Stock Gained 39.2% In 2025

    01/14 02:13 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: